GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea
· Delayed Price · Currency is KRW
9,520.00
-670.00 (-6.58%)
At close: Mar 9, 2026
GFC Life Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| Mar '26 Mar 6, 2026 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
| Debt / Equity Ratio | 0.90 | 0.90 | 1.51 | 0.85 | 0.64 | 0.34 | |
| Debt / EBITDA Ratio | 3.25 | 3.25 | 13.64 | 233.28 | - | - | |
| Debt / FCF Ratio | 20.79 | 20.79 | - | - | - | - | |
| Net Debt / Equity Ratio | 0.76 | 0.76 | 1.41 | 0.70 | 0.53 | 0.09 | |
| Net Debt / EBITDA Ratio | 2.72 | 2.72 | 12.80 | 191.73 | -5.07 | -0.93 | |
| Net Debt / FCF Ratio | 17.41 | 17.41 | -5.00 | -1.73 | -0.80 | -0.46 | |
| Asset Turnover | 0.71 | 0.71 | 0.65 | 0.60 | 0.49 | 0.46 | |
| Inventory Turnover | 11.18 | 11.18 | 12.84 | 11.69 | 8.75 | 9.38 | |
| Quick Ratio | 0.42 | 0.42 | 0.24 | 1.46 | 1.26 | 1.43 | |
| Current Ratio | 0.53 | 0.53 | 0.34 | 1.72 | 1.83 | 1.66 | |
| Return on Equity (ROE) | 21.78% | 21.78% | -28.76% | 4.26% | -4.65% | -8.67% | |
| Return on Assets (ROA) | 4.42% | 4.42% | -0.02% | -2.37% | -5.76% | -4.89% | |
| Return on Invested Capital (ROIC) | 8.82% | 8.82% | -0.04% | -4.28% | -11.51% | -11.63% | |
| Return on Capital Employed (ROCE) | 12.50% | 12.50% | -0.10% | -4.30% | -9.20% | -9.80% | |
| Buyback Yield / Dilution | 0.04% | -0.01% | -0.02% | -100.00% | 50.03% | -0.06% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.